Opalińska, M.; Sowa-Staszczak, A.; Wężyk, K.; Jagiełła, J.; Słowik, A.; Hubalewska-Dydejczyk, A.
Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging. J. Clin. Med. 2022, 11, 1537.
https://doi.org/10.3390/jcm11061537
AMA Style
Opalińska M, Sowa-Staszczak A, Wężyk K, Jagiełła J, Słowik A, Hubalewska-Dydejczyk A.
Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging. Journal of Clinical Medicine. 2022; 11(6):1537.
https://doi.org/10.3390/jcm11061537
Chicago/Turabian Style
Opalińska, Marta, Anna Sowa-Staszczak, Kamil Wężyk, Jeremiasz Jagiełła, Agnieszka Słowik, and Alicja Hubalewska-Dydejczyk.
2022. "Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging" Journal of Clinical Medicine 11, no. 6: 1537.
https://doi.org/10.3390/jcm11061537
APA Style
Opalińska, M., Sowa-Staszczak, A., Wężyk, K., Jagiełła, J., Słowik, A., & Hubalewska-Dydejczyk, A.
(2022). Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging. Journal of Clinical Medicine, 11(6), 1537.
https://doi.org/10.3390/jcm11061537